Epidemiology and risk factors for multi-drug resistant hospital-acquired urinary tract infection in patients with liver cirrhosis: single center experience in Serbia

Table 5 Risk factors associated with MDR HA-UTI

Risk factor	Univariate analysis		Multivariate analysis
Risk factor	OR (95% CI)	p	aOR (95% CI)	p
Age > 65 years	6.33 (1.66–24.10)	< 0.001	4.23 (1.39–12.89)	0.007
Autoimmune etiology of cirrhosis	8.50 (1.39–12.89)	0.006	3.88 (0.82–6.22)	0.08
Antibiotic use in the previous 7 days	3.30 (1.16–9.37)	0.002	2.66 (0.91–3.08)	0.29
Cephalosporin prophylaxis	4.70 (1.18–18.70)	0.001	3.61 (1.81–17.24)	0.04
Hepatic encephalopathy	3.38 (1.22–9.41)	< 0.001	4.99 (1.44–17.30)	0.01
BUN	1.08 (1.00–1.61)	0.01	1.01 (1.00–1.03)	0.14
Serum ferritin	1.01 (1.01–1.87)	0.04	0.84 (0.47–1.68)	0.62

This table presents risk factors associated with developement of MDR HA-UTI. MDR Multi-drug resistant, HA Hospital acquired, UTI Urinary tract infection, OR Odds ratio, CI Confidence interval, aOR Adjusted odds ratio, BUN Blood urea nitrogen

ISSN: 1471-2334